Timothy M. Ward, Esq. presented on biosimiliars at the 2019 New York State Bar Association Annual Meeting FDA Law Section held on Thursday, January 17, 2019 at the New York Hilton Midtown. Timothy is President of Hercules Pharmaceuticals, a VAWD accredited national specialty distributor and serves on the Board of Directors of the National Association of Specialty Pharmacy (NASP).
Before Hercules Pharmaceuticals, Tim was Chief Legal Officer of a multinational corporation, conducting business in highly regulated markets, as well as directing the group's government affairs efforts. Tim has served on boards for numerous Washington DC trade and industry groups, and participated in advisory committee capacity regarding economic sanctions, trade compliance and foreign policy.
Hercules Pharmaceuticals is a specialty distributor and actively engaged in the political fight to return market based economics to the drug supply chain and in fighting for transparency and fairness from the payor side.
For more information about this event, visit www.nysba.org/AM2019 To learn more about Hercules Pharmaceuticals, its accreditations, products, services and partnerships, please visit www.herculesrx.com
The Director, Business Development of Hercules Pharmaceuticals together with the 50th Speaker of U.S. House of Representatives, Newt Gingrich, at the NASP Annual meeting.
Hercules Pharmaceuticals, Inc. Hercules Pharmaceuticals, Inc. (Hercules Pharmaceuticals) attended the annual Community Oncology Alliance (COA) Conference held at National Harbor, Maryland. This year's conference centered on keeping patients and their needs paramount in transforming the National's cancer care system. Hercules Pharmaceuticals is a specialty distributor and actively engaged in the political fight to return market-based economics to the specialty pharmacy industry and in fighting for transparency and fairness from the payor side.
For more information about COA, visit their website at www.coaconference.org
To learn more about Hercules Pharmaceuticals, its accreditations, products, services and partnerships, please visit www.herculesrx.com
Hercules Pharmaceuticals is proud to announce its recent hire of Alyssa Mathies who will be the Company's newest Director, Business Development. Mathies will be responsible for seeking out new business opportunities and identifying potential market segments. She will develop, coordinate and implement plans designed to increase existing business and capture new opportunities.
During her spare time, Alyssa enjoys running and has even participated in the Brooklyn Half Marathon. Someday she plans to complete a full marathon. Her favorite season is summer and she enjoys cooking and baking, which is her means of relieving stress. She has a dog named Hayley
"The misuse of DIR Fees by PBMs is taking money out of the wallets of our sick and elderly, as well as out of the cash registers of the hard-working community pharmacies who serve them said Timothy Ward, President of Hercules Pharmaceuticals, a distributor who services the independent and community pharmacy sector. We must remove the calibrated distortions which benefit entrenched PBM interests, hurt the patients, and undermine the market."
To read more, please follow the links below:
Rep. Tom Suozzi visits N.Y. specialty pharmacy
Lawmaker seeks insight on drug cost dilemma